The authors of a recent Health Affairs blog post say patients and patient organizations with ties to industry and industry vendors should be required to disclose that relationship if they “weigh in on any issues.”
“Financial conflicts of interest among patients and patient advocacy organizations are as important as conflicts of interest among health care providers and professional organizations,” the authors, PharmedOut’s Judy Butler and Adriane Fugh-Berman, write. “Patients may overtake physicians as pharma’s best business partners. Transparency is a minimum standard for assessing whose views should carry most weight in public health debates.”
To read the full blog post, click here.